Concepedia

David E. Nichols

DE

Statistics

Publications

38

Citations

2K

H-Index

22

Active since

1984

Affiliations

Purdue University West Lafayette(Current)

University of North Carolina at Chapel Hill

Pennsylvania State University

Neuroscience Institute

University of California, San Francisco

David E. Nichols is an author at Purdue University West Lafayette specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1984–2025

38

Publications

38

Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist

William K. Brewster, David E. Nichols, Robert M. Riggs et al. · Journal of Medicinal Chemistry · 1990 · 170 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Serotonin 5-Hydroxytryptamine2A Receptor-Coupled Phospholipase C and Phospholipase A2 Signaling Pathways Have Different Receptor Reserves

Deborah Kurrasch‐Orbaugh, Val J. Watts, Eric L. Barker et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 165 citations

Life Sciences, Biochemistry, Pharmacology +17

WAY-100635 is a potent dopamine D4 receptor agonist

Benjamin R. Chemel, Bryan L. Roth, Blaine N. Armbruster et al. · Psychopharmacology · 2006 · 159 citations · Full text

Medicine, Neuroscience, Pharmacology +12

A complex signaling cascade links the serotonin<sub>2A</sub> receptor to phospholipase A<sub>2</sub> activation: the involvement of MAP kinases

Deborah Kurrasch‐Orbaugh, Jason C. Parrish, Val J. Watts et al. · Journal of Neurochemistry · 2003 · 133 citations

Life Sciences, Cell Biology, Pharmacology +17

Functional Selectivity of Dopamine Receptor Agonists. I. Selective Activation of Postsynaptic Dopamine D2 Receptors Linked to Adenylate Cyclase

David Mottola, Jason D. Kilts, Mechelle M. Lewis et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 123 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–5 of 38